Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
34,155,853
-
Shares change
-
+3,321,403
-
Total reported value, excl. options
-
$975,990,399
-
Value change
-
+$94,781,085
-
Number of buys
-
39
-
Number of sells
-
-29
-
Price
-
$28.57
Significant Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q2 2021
86 filings reported holding EPIX - ESSA Pharma Inc. - Common Shares, no par value per share as of Q2 2021.
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34,155,853 shares
of 47,601,550 outstanding shares and own 71.75% of the company stock.
Largest 10 shareholders include Blackstone Inc (3,303,103 shares), RTW INVESTMENTS, LP (3,053,919 shares), Avidity Partners Management LP (2,750,000 shares), Bellevue Group AG (2,459,814 shares), BVF INC/IL (2,451,561 shares), EVENTIDE ASSET MANAGEMENT, LLC (2,405,169 shares), Soleus Capital Management, L.P. (2,238,104 shares), JANUS HENDERSON GROUP PLC (2,017,894 shares), Vivo Capital, LLC (1,551,680 shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (1,350,000 shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.